You are here
Annexon, Inc.
Company Information
Address
180 Kimball Way Ste 200 Fl 2
South San Francisco, CA
94080-6218
United States
Information
UEI: KVPFLBUEA8C7
# of Employees: 6
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of novel inhibitors of C1q for the treatment of Neurodegenerative diseases
Amount: $1,213,915.00DESCRIPTION provided by applicant Alzheimerandapos s disease AD is the most common cause of dementia in the aging population and is a serious unmet medical social and economic problem worldwide ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
Development of novel inhibitors of complement for the treatment of Alzheimer's Di
Amount: $167,000.00DESCRIPTION (provided by applicant): The loss of synapses is an early hallmark of Alzheimer's disease (AD) preceding neuronal loss and predicting cognitive deficit. Dr Ben Bares, Annexon co-found ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health